Search

Searching with a thematic focus on HIV and AIDS treatment and care, HIV and AIDS

Showing 11-20 of 1199 results

Pages

• Document

  Valuing and compensating caregivers for their contributions to community health and development in the context of HIV and AIDS: an agenda for action

  Huairou Commission, 2010

  This paper concerns the valuation and compensation of caregivers for their ongoing contribution to community health and development in the context of HIV and AIDS.
• Document

  Funding Scientific Innovation: Global Investments in HIV Treatment Research and Development in 2010 and 2011

  2013

  Development of new, simpler, more effective and affordable compounds will continue to be essential for attaining the goal of putting at least 15 million people on ART by 2015, as set forth in the 2011 Political Declaration on HIV and AIDS. To this end, pharmaceutical industry leaders moved seven compounds into phase III studies in 2010 and 2011, and seven compounds into phase II.
• Document

  The Potential impact of free Trade agreements on Public health

  2012

  Over the past ten years, an increasing number of countries are initiating, negotiating and agreeing new trade agreements between two countries or amongst a group of countries. These are commonly known as free trade agreements or “FTAs”. They are promoted as providing significant economic benefits to signatory countries through the removal or reduction of barriers to trade in goods and services.
• Document

  Nutritional status of HIV-infected adults on antiretroviral therapy and the impact of nutritional supplementation in the Northern Cape Province, South Africa

  South African Journal of Clinical Nutrition, 2010

  The study was a descriptive prospective trial aimed to describe the nutritional status and impact of current nutrition intervention strategies on weight changes in adult HIV-infected patients on antiretroviral therapy. Results showed that patients from Kuruman had a greater incidence of underweight compared to other towns, with a median BMI of 17.9kg/sqmeter.
• Document

  MSMGF Technical Bulletin: Treatment 2.0

  2013

  This technical bulletin is a part of the MSM GF Technical Bulletin Series focusing on Treatment 2.0. What is Treatment 2.0? Designed and developed by UNAIDS and the WHO in June 2010, Treatment 2.0 is an overarching HIV/AIDS strategy that aims to markedly improve access to, and optimize the prevention benefit of, antiretroviral therapy (ART) globally.
• Document

  Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review

  Journal of the International AIDS Society, 2012

  Recent years have seen an increasing recognition of the need to improve access and retention in care for people living with HIV/AIDS.
• Document

  Assessing the population health impact of market interventions to improve access to antiretroviral treatment

  Health Policy and Planning, 2011

  Despite global progress in increasing coverage of antiretroviral treatment (ART), the majority of people needing ART currently are not receiving treatment.
• Document

  Time to act: save a million lives by 2015: prevent and treat among people living with HIV

  Joint United Nations Programme on HIV/AIDS, 2011

  Tuberculosis (TB) is the main cause of death in people living with HIV. This report is a call that TB should not be a death sentence for a two million people living with HIV and expected to die of TB between 2011 and 2015. The report highlights the following related facts and drawn findings:
• Document

  WHO recommended collaborative TB/HIV activities: evaluation of implementation and performance in a rural district hospital in Cameroon

  National Centre for Biotechnology Information, USA, 2011

  In response to the need of integrating tuberculosis (TB)/HIV activities, the WHO in 2004 mapped out a number of key activities to be implemented by countries to ensure effective collaboration between TB and HIV programmes.
• Document

  Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in Malawi

  Ingenta, 2011

  Malawian policy to invite patients co-infected with tuberculosis (TB) and HIV to start antiretroviral therapy (ART) 2 months after initiating TB treatment changed recently; the new policy shortened the period to 2 weeks instead of 2 months.

Pages